Cascadian Therapeutics (CASC)

0.97 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/8/18 *Est.)
- M&A (3/31/18 *Est)

Latest Headlines

Form SC 14D9/A Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc. February 16, 2018 4:41 PM - SEC Filing Form SC TO-T/A Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA February 16, 2018 4:30 PM - SEC Filing Seattle Genetics (SGEN) Announces Expiration of HSR Waiting Period for Acquisition of Cascadian (CASC) February 16, 2018 8:12 AM - StreetInsider Seattle Genetics Announces Expiration of Hart-Scott-Rodino Waiting Period February 16, 2018 8:00 AM - BizWire Form 5 Cascadian Therapeutics, For: Dec 31 Filed by: Walker Luke Nathaniel February 14, 2018 9:23 PM - SEC Filing Form SC 14D9/A Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc. February 14, 2018 6:15 PM - SEC Filing Form SC 13G/A Cascadian Therapeutics, Filed by: BAUPOST GROUP LLC/MA February 13, 2018 4:31 PM - SEC Filing Seattle Genetics (SGEN) Commences Tender Offer for Cascadian Therapeutics (CASC) February 8, 2018 5:43 PM - StreetInsider Seattle Genetics Commences Tender Offer for Cascadian Therapeutics, Inc. February 8, 2018 5:39 PM - BizWire Form SC 14D9 Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc. February 8, 2018 5:29 PM - SEC Filing Form SC TO-T Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA February 8, 2018 5:27 PM - SEC Filing Form SC TO-C Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA February 7, 2018 5:25 PM - SEC Filing Form 8-K Cascadian Therapeutics, For: Feb 01 February 7, 2018 4:41 PM - SEC Filing Form SC 13G/A Cascadian Therapeutics, Filed by: FRANKLIN RESOURCES INC February 6, 2018 11:40 AM - SEC Filing RM LAW Announces Investigation of Cascadian Therapeutics, Inc. February 6, 2018 11:21 AM - PR NewsWire Form 4 Cascadian Therapeutics, For: Feb 01 Filed by: Walker Luke Nathaniel February 2, 2018 5:56 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Feb 01 Filed by: PETERSON SCOTT ROBERT February 2, 2018 5:56 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Feb 01 Filed by: Myers Scott Dunseth February 2, 2018 5:55 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Feb 01 Filed by: EASTLAND JULIA MARIE February 2, 2018 5:54 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Feb 01 Filed by: Christianson Gary February 2, 2018 5:53 PM - SEC Filing Form SC 13G Cascadian Therapeutics, Filed by: BlackRock Inc. February 1, 2018 9:30 AM - SEC Filing Form SC TO-C Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA January 31, 2018 5:29 PM - SEC Filing Pre-Open Movers 01/31: (CASC) (SFLY) (KNX) Higher; (BLCM) (MGI) (CACC) Lower (more...) January 31, 2018 9:24 AM - StreetInsider Form SC14D9C Cascadian Therapeutics, Filed by: Cascadian Therapeutics, Inc. January 31, 2018 7:23 AM - SEC Filing Form 8-K Cascadian Therapeutics, For: Jan 30 January 31, 2018 7:17 AM - SEC Filing Form SC TO-C Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA January 31, 2018 6:50 AM - SEC Filing Form SC TO-C Cascadian Therapeutics, Filed by: SEATTLE GENETICS INC /WA January 31, 2018 6:46 AM - SEC Filing Seattle Genetics (SGEN) to Acquire Cascadian Therapeutics (CASC) for $10/Share January 31, 2018 6:31 AM - StreetInsider Seattle Genetics to Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program to Its Oncology Pipeline January 31, 2018 6:30 AM - BizWire Form EFFECT Cascadian Therapeutics, January 19, 2018 6:02 AM - SEC Filing Form 4 Cascadian Therapeutics, For: Jan 11 Filed by: Walker Luke Nathaniel January 16, 2018 5:30 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Jan 11 Filed by: PETERSON SCOTT ROBERT January 16, 2018 5:29 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Jan 11 Filed by: Myers Scott Dunseth January 16, 2018 5:27 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Jan 11 Filed by: EASTLAND JULIA MARIE January 16, 2018 5:25 PM - SEC Filing Form 4 Cascadian Therapeutics, For: Jan 11 Filed by: Christianson Gary January 16, 2018 5:25 PM - SEC Filing Cascadian Therapeutics (CASC) Announces 2018 Outlook January 4, 2018 8:37 AM - StreetInsider Cascadian Therapeutics Announces 2018 Outlook and Recent Progress January 4, 2018 8:30 AM - Globe NewsWire Cascadian Therapeutics Announces 2018 Outlook and Recent Progress January 4, 2018 8:30 AM - StreetInsider Cascadian Therapeutics (CASC) Granted Pediatric Investigation Plan Waiver from the European Medicines Agency January 2, 2018 8:31 AM - StreetInsider Cascadian Therapeutics (CASC) Receives Pediatric Investigation Plan Waiver from EMA January 2, 2018 8:31 AM - StreetInsider Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency January 2, 2018 8:30 AM - Globe NewsWire Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency January 2, 2018 8:30 AM - StreetInsider Cascadian Therapeutics (CASC) files $250 million mixed securities shelf December 29, 2017 4:21 PM - StreetInsider Form S-3 Cascadian Therapeutics, December 29, 2017 4:10 PM - SEC Filing Cascadian Therapeutics Added to the Nasdaq Biotechnology Index December 13, 2017 8:35 AM - Globe NewsWire Cascadian Therapeutics Added to the Nasdaq Biotechnology Index December 13, 2017 8:35 AM - StreetInsider Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer December 7, 2017 4:05 PM - Globe NewsWire Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer December 7, 2017 4:05 PM - StreetInsider Form 8-K Cascadian Therapeutics, For: Dec 04 December 7, 2017 6:03 AM - SEC Filing Full Article List